NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2023
Back to search
Official data from USPTO
K
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
10/03/2023
Trademark type
Combined
Nice classes
5
Filing date
02/10/2022
Registration date
10/03/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/03/2023
Last transaction
10/03/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
TOKYO, JP
Examiner
BECKER, JOSEPH RAPHAEL
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of three opaque rectangles aligned on different axes.
Holders and representatives
Holders
KAKEN PHARMACEUTICAL CO., LTD.
Representatives
Christopher Weimer Pirkey Barber PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antibiotics; Fungicides; Herbicides; Insecticides; Pharmaceutical preparations for the treatment of disorders and diseases of the central nervous systemperipheral nervous systemmusculoskeletal systemrespiratory systemurogenital systemcardiovascular systemendocrine systemmetabolic systemimmune systemrenal systemgastroenterologic systemophthalmologic system; Pharmaceutical preparations for the treatment of hematologic and oncologic disorders and diseasespsychiatric disorders and diseasesorthopaedic disorders and diseasesdermatologic disorders and diseasesdental disorders and diseasesallergic disorders and diseasesautoimmunological diseases and disorders; Pharmaceutical preparations for the treatment of the bacteriafungusvirus infections
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/18/2023
PUBO
PUBLISHED FOR OPPOSITION
07/18/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/28/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/31/2023
GNRT
NON-FINAL ACTION E-MAILED
05/31/2023
CNRT
NON-FINAL ACTION WRITTEN
05/31/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/31/2023
OTHE
CASE RETURNED TO EXAMINATION
05/15/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/15/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
05/10/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
05/10/2023
APET
ASSIGNED TO PETITION STAFF
05/09/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
04/26/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/19/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/19/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/19/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2023
PUBO
PUBLISHED FOR OPPOSITION
01/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2022
DOCK
ASSIGNED TO EXAMINER
11/23/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/15/2022
NWAP
NEW APPLICATION ENTERED
02/14/2022
Continuous trademark protection
Get notified about every new filing that threatens K or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.